Figure 5
Figure 5. Recombinant CCN1 inhibits MM cell growth in vitro. (A) H929 MM cells were incubated for indicated times alone (control; black) with recombinant CCN1 at 1 μg/mL (green), 2 μg/mL (blue), or 5 μg/mL (red). Cells exposed to 2 μg/mL CCN1 at 24 hours and 5 μg/mL CCN1 at 24, 48, 72, and 96 hours had significantly lower cell numbers than untreated controls (P < .01 and P < .001, respectively) (B) Luciferase-expressing stroma-dependent MM cell lines were cocultured with MSCs with increasing doses (μg/mL) of recombinant CCN1 for 7 days, and MM cell growth was determined every 24 hours from bioluminescence intensity.

Recombinant CCN1 inhibits MM cell growth in vitro. (A) H929 MM cells were incubated for indicated times alone (control; black) with recombinant CCN1 at 1 μg/mL (green), 2 μg/mL (blue), or 5 μg/mL (red). Cells exposed to 2 μg/mL CCN1 at 24 hours and 5 μg/mL CCN1 at 24, 48, 72, and 96 hours had significantly lower cell numbers than untreated controls (P < .01 and P < .001, respectively) (B) Luciferase-expressing stroma-dependent MM cell lines were cocultured with MSCs with increasing doses (μg/mL) of recombinant CCN1 for 7 days, and MM cell growth was determined every 24 hours from bioluminescence intensity.

Close Modal

or Create an Account

Close Modal
Close Modal